BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Heyse M, Schneider C, Monostori P, Schwarz KV, Hauke J, Drüschler K, Berberich A, Zorn M, Ringleb PA, Okun JG, Mundiyanapurath S. Trimethylamine-N-Oxide Levels Are Similar in Asymptomatic vs. Symptomatic Cerebrovascular Atherosclerosis. Front Neurol 2021;12:617944. [PMID: 33815248 DOI: 10.3389/fneur.2021.617944] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Gao M, Heng X, Jin J, Chu W. Gypenoside XLIX Ameliorate High-Fat Diet-Induced Atherosclerosis via Regulating Intestinal Microbiota, Alleviating Inflammatory Response and Restraining Oxidative Stress in ApoE−/− Mice. Pharmaceuticals 2022;15:1056. [DOI: 10.3390/ph15091056] [Reference Citation Analysis]
2 Mudimela S, Vishwanath NK, Pillai A, Morales R, Marrelli SP, Barichello T, Giridharan VV. Clinical significance and potential role of trimethylamine N-oxide in neurological and neuropsychiatric disorders. Drug Discov Today 2022:S1359-6446(22)00304-X. [PMID: 35998800 DOI: 10.1016/j.drudis.2022.08.002] [Reference Citation Analysis]
3 Zou Y, Song X, Liu N, Sun W, Liu B. Intestinal Flora: A Potential New Regulator of Cardiovascular Disease. Aging and disease 2022;13:753. [DOI: 10.14336/ad.2021.1022] [Reference Citation Analysis]